CRISPR primes goldenberry for fruit bowl fame
On Dec. 19, 2025, Cold Spring Harbor Laboratory (CSHL) plant biologists may have found a “shortcut” to this…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
Biotechnology | CRISPR | Disease | FDA | Genomics | Stem Cell | Therapeutics
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
On Dec. 8, 2025, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | FDA | Genomics | HIV | Infectious Disease | Influenza | Nanotechnology | Neurology | NIH | Oncology | Organ Transplant | Rare Disease | Stem Cell | Therapeutics | U.S. Congress | Vaccine | Women's Health
Halted NIH Clinical Trials List Reveals Slashed Treatments for Cancer, COVID and Minority Health
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
CRISPR breakthrough reverses chemotherapy resistance in lung cancer
On Nov. 17, 2025,In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have…
Hope for diabetes: CRISPR-edited cells pump out insulin in a person — and evade immune detection
On Sept. 5, 2025, in a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into…
Georgia State Scientists Revive Ancient Gene to Target Gout, Fatty Liver Disease
On Aug. 26, 2025, scientists at Georgia State University (GSU) announced a study published in Scientific Reports that…
Mars Partners with Pairwise to Accelerate Cacao Research Using CRISPR platform
On Aug. 6, Mars has licensed Pairwise’s Fulcrum® gene editing tools for cacao research and development. This licensing…
Agriculture | Artificial Intelligence | Biotechnology | COVID-19 | CRISPR | Diagnostics | Genomics | Infectious Disease | Materials | Medical Device | Stem Cell | Therapeutics | Vaccine
China approving innovative drugs at record pace as discovery momentum shifts from the West
On Jul. 24, 2025, The China Times reported that China is making inroads in the race for innovative…
Scientists apply optical pooled CRISPR screening to identify potential new Ebola drug targets
On Jul. 24, 2025, researchers at the Broad Institute and the National Emerging Infectious Diseases Laboratories (NEIDL) at…
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Colossal Targets Moa as Its Next Species Restoration Milestone
On Jul. 8, 2025, Colossal Biosciences announced the moa as its next de-extinction focus, continuing its mission to…
Chan Zuckerberg Initiative, Innovative Genomics Institute Announce New Center for Pediatric CRISPR Cures
On Jul. 8, 2025, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced the funding of the…
Scientists create biological ‘artificial intelligence’ system
On Jul. 7, 2025, Australian scientists, including at the Charles Perkins Centre, University of Sydney, have successfully developed…
Precision gene editing medicine makes history, and it’s just getting started
On Jun. 30, 2025, as in something out of science fiction, a team of researchers reached into the…
World’s first patient treated with personalized CRISPR gene editing therapy at Children’s Hospital of Philadelphia
On May 15, 2025, a team at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine announced that a…
Agriculture Minister Announces Two Genome-Edited Rice Varieties Developed in India, a World First
On May 4, 2025, Union Agriculture and Farmers Welfare Minister Shri Shivraj Singh Chouhan announced that two genome-edited…
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Colossal Biosciences announces de-extinction of dire wolf
On Apr. 7, 2025, scientists at Colossal Biosciences announced the successful de-extinction of the dire wolf with the…
Europe steps up recruitment of U.S. scientists
On April 3, France’s Université Paris-Saclay said it is one of dozens of European institutions ramping up efforts…
Biotechnology | CRISPR | Disease | Genomics | Oncology | Therapeutics
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Scientists from Colossal Biosciences genetically engineer mice with extinct woolly mammoth
On Mar. 4, 2025, Colossal Biosciences announced that its scientists have simultaneously edited seven genes in mice embryos…
Agriculture | Artificial Intelligence | Biotechnology | CRISPR | Diagnostics | Genomics | Infectious Disease | Influenza | Medical Device | NIH | Oncology | Therapeutics | Vaccine
U.S. Implements New Export Controls to Address National Security Risks Related to Biotechnology
On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…
New CRISPR Toolkit to Allow Remote-Controlled Genome Editing
On Dec. 2, 2024, engineers in the University of Southern California (USC) Alfred E. Mann Department of Biomedical…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
Biotechnology | CRISPR | Genomics | USDA
USDA-APHIS Determined Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the U.S.
On Mar. 21, 2024, Yield10 Bioscience announced that USDA-APHIS’s Biotechnology Regulatory Services (“BRS”) has determined that Yield10’s Camelina…
European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
Biotechnology | CRISPR | Disease | FDA | Therapeutics
CRISPR Therapeutics announced FDA approval of CASGEVY for treatment of ransfusion-dependent beta thalassemia
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, in a study of historic scale, scientists at Gladstone Institutes announced that they had…
CRISPR | Genomics | Stem Cell | Therapeutics
FDA approved first gene therapies to treat patients with sickle cell disease
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
Biotechnology | CRISPR | FDA | Genomics | Therapeutics
Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…